BioStem Technologies, Inc.
BSEM
$3.71
-$0.25-6.22%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | 4.10M | 10.16M | 10.74M | 17.01M |
| Total Depreciation and Amortization | -- | 283.00K | 230.90K | 230.90K | 230.10K |
| Total Amortization of Deferred Charges | -- | 63.60K | 101.80K | 101.80K | 217.30K |
| Total Other Non-Cash Items | -- | 5.78M | 5.35M | 5.35M | 4.32M |
| Change in Net Operating Assets | -- | -3.12M | 3.06M | 2.49M | -1.95M |
| Cash from Operations | -- | 7.11M | 18.91M | 18.91M | 19.84M |
| Capital Expenditure | -- | -2.91M | -616.80K | -616.80K | -447.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 1.25M | -1.25M | -1.25M | -1.25M |
| Cash from Investing | -- | -1.66M | -1.87M | -1.87M | -1.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -1.17M | -1.13M | -1.13M | -461.70K |
| Issuance of Common Stock | -- | 48.30K | 133.30K | 133.30K | 133.30K |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -- | -1.12M | -993.00K | -993.00K | -328.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 4.33M | 16.05M | 16.05M | 17.81M |